LKB1 Is the Upstream Kinase in the AMP-Activated Protein Kinase Cascade

Current Biology

Volumn 13, Issue 22, 2003, Pages 2004-2008

  Woods, Angela ^a   Johnstone, Stephen R ^a   Dickerson, Kristina ^a   Leiper, Fiona C ^a   Fryer, Lee G D ^a   Neumann, Dietbert ^b   Schlattner, Uwe ^b   Wallimann, Theo ^b   Carlson, Marian ^c   Carling, David ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b ETH ZURICH   (Switzerland)

^c Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA;

EID: 10744230065     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cub.2003.10.031     Document Type: Article

References (24)

1. Jenne, D.E., Reimann, H., Nezu, J.I., Friedel, W., Loff, S., Jeschke, R., Müller, O., Back, W., and Zimmer, M. (1998). Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat. Genet. 18, 38-43.
2. Hemminki, A., Markie, D., Tomlinson, I., Avizienyte, E., Roth, S., Loukola, A., Bignell, G., Warren, W., Aminoff, M., Hoglund, P., et al. (1998). A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature 391, 184-187.
3. Baas, A.F., Boudeau, J., Sapkota, G.P., Smit, L., Medema, R., Morrice, N.A., Alessi, D.R., and Clevers, H.C. (2003). Activation of the tumour suppressor kinase LKB1 by the STE20-like pseudokinase STRAD. EMBO J. 22, 3062-3072.
4. Hardie, D.G., Carling, D., and Carlson, M. (1998). The AMP-activated/ SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell? Annu. Rev. Biochem. 67, 821-855.
5. Winder, W.W., and Hardie, D.G. (1999). AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes. Am. J. Physiol. 277, 1-10.
6. Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001). Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest. 108, 1167-1174.
7. Minokoshi, Y., Kim, Y.B., Peroni, O.D., Fryer, L.G., Muller, C., Carling, D., and Kahn, B.B. (2002). Leptin stimulates fatty acid oxidation by activating AMP-activated protein kinase. Nature 415, 339-343.
8. Blair, E., Redwood, C., Ashrafian, H., Ostman-Smith, I., and Watkins, H. (2001). Mutations in the γ2 subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis. Hum. Mol. Genet. 10, 1215-1220.
9. Hong, S.P., Leiper, F.C., Woods, A., Carling, D., and Carlson, M. (2003). Activation of yeast Snf1 and mammalian AMP-activated protein kinase by upstream kinases. Proc. Natl. Acad. Sci. USA 100, 8839-8843.
10. Hawley, S.A., Davison, M.D., Woods, A., Davies, S.P., Beri, R.K., Carling, D., and Hardie, D.G. (1996). Characterisation of the AMP-activated protein kinase kinase from rat liver and identification of threonine-172 as the major site at which it phosphorylates AMP-activated protein kinase. J. Biol. Chem. 271, 27879-27887.
11. Cheung, P.C.F., Salt, I.P., Davies, S.P., Hardie, D.G., and Carling, D. (2000). Characterization of AMP-activated protein kinase γ-subunit isoforms and their role in AMP binding. Biochem. J. 346, 659-669.
12. 2+/calmodulin activates the calmodulin- dependent protein kinase-l cascade, via 3 independent mechanisms. J. Biol. Chem. 270, 27186-27191.
13. Hamilton, S.R., O'Donnell, J.B., Hammet, A., Stapleton, D., Habinowski, S.A., Means, A.R., Kemp, B.E., and Witters, L.A. (2002). AMP-activated protein kinase kinase: detection with recombinant AMPK α1 subunit. Biochem. Biophys. Res. Commun. 293, 892-898.
14. Neumann, D., Woods, A., Carling, D., Wallimann, T., and Schlattner, U. (2003). Mammalian AMP-activated protein kinase: functional, heterotrimeric complexes by co-expression of subunits in Escherichia coli. Protein Expr. Purif. 30, 230-237.
15. Sapkota, G.P., Boudeau, J., Deak, M., Kieloch, A., Morrice, N., and Alessi, D.R. (2002). Identification and characterization of four novel phosphorylation sites (Ser31, Ser325, Thr336 and Thr366) on LKB1/STK11, the protein kinase mutated in Peutz-Jeghers cancer syndrome. Biochem. J. 362, 481-490.
16. Fryer, L.G., Patel, A.P., and Carling, D. (2002). The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct pathways. J. Biol. Chem. 277, 25226-25232.
17. Sullivan, J.E., Brocklehurst, K.J., Marley, A.E., Carey, F., Carling, D., and Beri, R.K. (1994). Inhibition of lipolysis and lipogenesis in isolated rat adipocytes with AICAR, a cell-permeable activator of AMP-activated protein kinase. FEBS Lett. 353, 33-36.
18. Tiainen, M., Ylikorkala, A., and Makela, T.P. (1999). Growth suppression by Lkb1 is mediated by a G1 cell cycle arrest. Proc. Natl. Acad. Sci. USA 96, 9248-9251.
19. Boudeau, J., Deak, M., Lawlor, M.A., Morrice, N.A., and Alessi, D.R. (2003). Heat-shock protein 90 and Cdc37 interact with LKB1 and regulate its stability. Biochem. J. 370, 849-857.
20. 2. Biochem. Biophys. Res. Commun. 287, 92-97.
21. Sutherland, C.M., Hawley, S.A., McCartney, R.R., Leech, A., Stark, M.J.R., Schmidt, M.C., and Hardie, D.G. (2003). Elm1p is one of three upstream kinases for the Saccharomyces cerevisiae SNF1 complex. Curr. Biol. 13, 1299-1305.
22. Li, J., Jiang, P., Robinson, M., Lawrence, T.S., and Sun, Y. (2003). AMPK-β1 subunit is a p53-independent stress responsive protein that inhibits tumor cell growth upon forced expression. Carcinogenesis 24, 827-834.
23. Wang, W., Yang, X., Lopez de Silanes, I., Carling, D., and Gorospe, M. (2003). Increased AMP:ATP ratio and AMP-activated protein kinase activity during cellular senescence linked to reduced HuR function. J. Biol. Chem. 278, 27016-27023.
24. Yoo, L.I., Chung, D.C., and Yuan, J. (2002). LKB1-a master tumour suppressor of the small intestine and beyond. Nat. Rev. Cancer 2, 529-535.